Update on statin drugs for lipid disorders

Update on statin drugs for lipid disorders Geriatric Nursing 39 (2018) 350–351 Contents lists available at ScienceDirect Geriatric Nursing journal homepage: www.gnjournal.com Pharmacy Column William Simonson, PharmD, BCGP, FASCP William Simonson, PharmD, BCGP, FASCP * Oregon State University, Corvallis, OR, USA Statin drugs are one of the most commonly used classes of medi- statins that substantially expanded the population eligible for statin cations, and one of the most controversial. The first statin, lovastatin, therapy. They based their recommendations on an estimated el- was approved by the US Food and Drug Administration (FDA) in 1987. evated 10-year risk of atherosclerotic cardiovascular disease by Additional statins received FDA approval, mostly in the 1990’s. Statins basically identifying four high-risk groups: individuals who had now available as single agent products include atorvastatin (Lipitor), already experienced a cardiovascular event (stroke or heart attack), fluvastatin (Lescol, Lescol XL), lovastatin (Mevacor, Altoprev), diabetics between the age of 40 and 69, persons with an elevated pravastatin (Pravachol), rosuvastatin (Crestor), simvastatin (Zocor, LDL, and older men. These guidelines are based on an estimation FloLipid) and pitavastatin (Livalo) and some statins are available in of an individual’s risk of experiencing a cardiovascular event in the combination products. Fifteen million Americans now take statin next ten years. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Geriatric Nursing Elsevier

Update on statin drugs for lipid disorders

Loading next page...
 
/lp/elsevier/update-on-statin-drugs-for-lipid-disorders-9QoN13mcPY
Publisher
Elsevier
Copyright
Copyright © 2018 Elsevier Inc.
ISSN
0197-4572
eISSN
1528-3984
D.O.I.
10.1016/j.gerinurse.2018.04.016
Publisher site
See Article on Publisher Site

Abstract

Geriatric Nursing 39 (2018) 350–351 Contents lists available at ScienceDirect Geriatric Nursing journal homepage: www.gnjournal.com Pharmacy Column William Simonson, PharmD, BCGP, FASCP William Simonson, PharmD, BCGP, FASCP * Oregon State University, Corvallis, OR, USA Statin drugs are one of the most commonly used classes of medi- statins that substantially expanded the population eligible for statin cations, and one of the most controversial. The first statin, lovastatin, therapy. They based their recommendations on an estimated el- was approved by the US Food and Drug Administration (FDA) in 1987. evated 10-year risk of atherosclerotic cardiovascular disease by Additional statins received FDA approval, mostly in the 1990’s. Statins basically identifying four high-risk groups: individuals who had now available as single agent products include atorvastatin (Lipitor), already experienced a cardiovascular event (stroke or heart attack), fluvastatin (Lescol, Lescol XL), lovastatin (Mevacor, Altoprev), diabetics between the age of 40 and 69, persons with an elevated pravastatin (Pravachol), rosuvastatin (Crestor), simvastatin (Zocor, LDL, and older men. These guidelines are based on an estimation FloLipid) and pitavastatin (Livalo) and some statins are available in of an individual’s risk of experiencing a cardiovascular event in the combination products. Fifteen million Americans now take statin next ten years.

Journal

Geriatric NursingElsevier

Published: May 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off